A股異動 | 威孚高科漲近5% 擬以約6000萬歐元收購VHIT及VHCN100%股權
格隆匯2月9日丨威孚高科(000581.SZ)盤中漲4.76%,報22.44元,總市值226億元。威孚高科2月8日公吿,公司擬採用現金方式以約6000萬歐元的交易對價向RBIT購買其所持有的VHIT及其全資子公司VHCN的100%股權。標的公司正在研發和推進市場應用的新能源汽車熱管理系統核心子系統“電子油泵”產品技術,已經獲取多家國際客户項目及多家國內新能源頭部客户項目,預計2022年下半年陸續進入批產階段,市場前景廣闊。公司將以此次交易為契機,以電子油泵這一戰略新產品業務切入“新能源汽車熱管理系統及核心零部件”領域。此次交易構成關聯交易。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.